← Leaderboards
John W Mellors
University Of Pittsburgh At Pittsburgh
$70,850,753
Attributed
$136,079,177
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$136,079,177 · 15
By mechanism
UM1$95,026,424 · 4
U01$31,437,814 · 3
R01$6,119,942 · 2
K12$1,729,859 · 1
T32$1,330,452 · 1
R21$432,824 · 1
Top collaborators
- Sharon Riddler20 shared
- Susan L Koletar15 shared
- Alison Morris12 shared
- Dan H. Barouch10 shared
- Sandhya Vasan6 shared
- Bernard Jonas C Macatangay5 shared
- Solomon Fiifi Ofori-Acquah5 shared
- Nelson Lee Michael4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Nicolas P Sluis-Cremer$13,171,852
- Sharon Riddler$22,034,939
- Susan L Koletar$31,986,005
- Rieko Ishima$4,470,162
- Alexander Deiters$7,387,118
Others in their field
Top investigators on “Virology”
- Constance Ann Benson · University Of California, San Diego$244,103,553
- Daniel R Kuritzkes · Brigham And Women'S Hospital$241,021,487
- David Heimbrook · Leidos Biomedical Research, Inc.$233,980,072
- Lawrence Corey · Fred Hutchinson Cancer Center$221,430,346
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$210,965,283
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$171,881,579
Research focus
VirologyResearch PersonnelClinical ResearchLaboratoriesEvaluationCommunitiesClinical TrialsUniversitiesMentorsImmunologyAreaHiv-1EpidemicProtocols DocumentationAcquired Immunodeficiency SyndromeClinical Research SiteEnsureLeadershipInfectionPerformanceParticipantComorbidityClinical Trials UnitFollow-Up
Grant awards (84)
I4C 2.0: Immunotherapy for Cure$4,653,643
UM1 · FY2025 · AI
Pitt-Ohio State Clinical Trials Unit$2,382,302
UM1 · FY2025 · AI
Pitt-Ohio State Clinical Trials Unit$1,083,959
UM1 · FY2025 · AI
Pitt-Ohio State Clinical Trials Unit$119,250
UM1 · FY2025 · AI
I4C 2.0: Immunotherapy for Cure$4,423,055
UM1 · FY2024 · AI
Pitt-Ohio State Clinical Trials Unit$2,310,879
UM1 · FY2024 · AI
I4C 2.0: Immunotherapy for Cure$4,669,992
UM1 · FY2023 · AI
Pitt-Ohio State Clinical Trials Unit$2,468,833
UM1 · FY2023 · AI · contact PI
I4C 2.0: Immunotherapy for Cure$4,677,761
UM1 · FY2022 · AI
Pitt-Ohio State Clinical Trials Unit$2,355,644
UM1 · FY2022 · AI · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$391,026
K12 · FY2022 · HL
I4C 2.0: Immunotherapy for Cure$4,904,730
UM1 · FY2021 · AI
Pitt-Ohio State Clinical Trials Unit$2,344,903
UM1 · FY2021 · AI · contact PI
Laboratory Center (LC): Microbicide Trials Network$2,058,087
UM1 · FY2021 · AI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure$1,184,950
U01 · FY2021 · AI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$415,675
K12 · FY2021 · HL
Combined Immunologic Approaches to Cure HIV-1$4,630,463
UM1 · FY2020 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit$2,751,253
UM1 · FY2020 · AI · contact PI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure$1,879,702
U01 · FY2020 · AI
Laboratory Center (LC): Microbicide Trials Network$691,454
UM1 · FY2020 · AI
Pitt-Ohio State Clinical Trials Unit Administrative Supplement$533,144
UM1 · FY2020 · AI · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$411,577
K12 · FY2020 · HL
Laboratory Center (LC): Microbicide Trials Network$5,656,261
UM1 · FY2019 · AI
Combined Immunologic Approaches to Cure HIV-1$5,042,075
UM1 · FY2019 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit$3,366,355
UM1 · FY2019 · AI · contact PI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure$1,387,573
U01 · FY2019 · AI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$412,499
K12 · FY2019 · HL
Combined Immunologic Approaches to Cure HIV-1$4,630,463
UM1 · FY2018 · AI
Laboratory Center (LC): Microbicide Trials Network$4,376,162
UM1 · FY2018 · AI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure$1,871,420
U01 · FY2018 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit$1,528,540
UM1 · FY2018 · AI · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$99,082
K12 · FY2018 · HL
Combined Immunologic Approaches to Cure HIV-1$4,630,463
UM1 · FY2017 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit$1,491,683
UM1 · FY2017 · AI · contact PI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure$1,065,423
U01 · FY2017 · AI
Longitudinal evaluation of HIV-associated lung disease phenotypes$724,214
R01 · FY2017 · HL
Longitudinal evaluation of HIV-associated lung disease phenotypes$190,626
R01 · FY2017 · HL
Combined Immunologic Approaches to Cure HIV-1$4,630,463
UM1 · FY2016 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit$1,491,683
UM1 · FY2016 · AI · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$727,308
R01 · FY2016 · HL
Longitudinal evaluation of HIV-associated lung disease phenotypes$64,994
R01 · FY2016 · HL
PItt-Ohio State-Georgetown Clinical Trials Unit$1,446,339
UM1 · FY2015 · AI · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$727,478
R01 · FY2015 · HL
Simplified Assays of Latent But Inducible HIV-1 Reservoirs$228,881
R21 · FY2015 · AI · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$63,280
R01 · FY2015 · HL
PItt-Ohio State-Georgetown Clinical Trials Unit$4,102,856
UM1 · FY2014 · AI · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$770,898
R01 · FY2014 · HL
Simplified Assays of Latent But Inducible HIV-1 Reservoirs$203,943
R21 · FY2014 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$3,099,468
UM1 · FY2013 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$2,474,261
UM1 · FY2012 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$2,455,069
U01 · FY2011 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$220,000
U01 · FY2011 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$75,750
U01 · FY2011 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$2,768,591
U01 · FY2010 · AI · contact PI
Rational Design of NRTI for Drug Resistant HIV-1$600,408
R01 · FY2010 · AI · contact PI
Rational Design of NRTI for Drug Resistant HIV-1$486,282
R01 · FY2010 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$75,750
U01 · FY2010 · AI · contact PI
IMPACT OF ANTIRETROVIRAL PREVENTION ON EMERGENCE AND SPREAD OF HIV DRUG RESISTA$1,091
P41 · FY2010 · RR · contact PI
University of Pittsburgh Clinical Trials Unit$3,455,746
U01 · FY2009 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$631,756
U01 · FY2009 · AI · contact PI
Rational Design of NRTI for Drug Resistant HIV-1$590,913
R01 · FY2009 · AI · contact PI
Training in AIDS Molecular Epi/Microbiology & STDs$69,019
T32 · FY2009 · AI · contact PI
IMPACT OF ANTIRETROVIRAL PREVENTION ON EMERGENCE AND SPREAD OF HIV DRUG RESISTA$771
P41 · FY2009 · RR · contact PI
University of Pittsburgh Clinical Trials Unit$2,256,665
U01 · FY2008 · AI · contact PI
Rational Design of NRTI for Drug Resistant HIV-1$575,802
R01 · FY2008 · AI · contact PI
Training in AIDS Molecular Epi/Microbiology & STDs$130,414
T32 · FY2008 · AI · contact PI
University of Pittsburgh Clinical Trials Unit$1,948,098
U01 · FY2007 · AI · contact PI
Rational Design of NRTI for Drug Resistant HIV-1$597,739
R01 · FY2007 · AI · contact PI
Training in AIDS Molecular Epi/Microbiology & STDs$130,007
T32 · FY2007 · AI · contact PI
ADULT AIDS CLINICAL TRIALS UNIT$1,514,015
U01 · FY2006 · AI · contact PI
Training in AIDS Molecular Epi/Microbiology & STDs$127,999
T32 · FY2006 · AI · contact PI
ADULT AIDS CLINICAL TRIALS UNIT$1,638,888
U01 · FY2005 · AI
Training in AIDS Molecular Epi/Microbiology &STDs$129,813
T32 · FY2005 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,588,110
U01 · FY2004 · AI
TRAINING IN AIDS &MOLECULAR MICROBIOLOGY/EPIDEMIOLOGY$151,239
T32 · FY2004 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,486,956
U01 · FY2003 · AI
TRAINING IN AIDS &MOLECULAR MICROBIOLOGY/EPIDEMIOLOGY$169,561
T32 · FY2003 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,837,094
U01 · FY2002 · AI
TRAINING IN AIDS &MOLECULAR MICROBIOLOGY/EPIDEMIOLOGY$161,617
T32 · FY2002 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,227,954
U01 · FY2001 · AI
TRAINING IN AIDS &MOLECULAR MICROBIOLOGY/EPIDEMIOLOGY$149,561
T32 · FY2001 · AI
ADULT AIDS CLINICAL TRIALS UNIT$868,304
U01 · FY2000 · AI
TRAINING IN AIDS &MOLECULAR MICROBIOLOGY/EPIDEMIOLOGY$111,222
T32 · FY2000 · AI
CLINICAL CENTER FOR VIRAL ACTIVATION TRANSFUSION STUDY$0
N01 · FY2000 · HB